Cenobamat – eine neue Perspektive für die Epilepsietherapie
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Neurology (clinical),Neurology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00115-020-01000-0.pdf
Reference46 articles.
1. Arnold S (2020) Cenobamate: new hope for treatment-resistant epilepsy. Lancet Neurol 19(1):23–24. https://doi.org/10.1016/S1474-4422(19)30434-X
2. Ben-Menachem E, Mameniskiene R, Quarato PP, Klein P, Gamage J, Schiemann J, Johnson ME, Whitesides J, McDonough B, Eckhardt K (2016) Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies. Neurology 87(3):314–323. https://doi.org/10.1212/WNL.0000000000002864
3. Binnie C (2001) Proof of principle trials: EEG surrogate endpoints. Epilepsy Res 45:7–11
4. Binnie CD, Kasteleijn-Nolst Trenité DGA, De Korte R (1986) Photosensitivity as a model for acute antiepileptic drug studies. Electroencephalogr Clin Neurophysiol 63:35–41
5. Binnie CD, van Emde Boas W, Kasteleijn-Nolste-Trenité D, de Korte RA, Meijer JW, Meinardi H, Miller AA, Overweg J, Peck AW, van Wieringen A et al (1986) Acute effects of lamotrigine (BW430C) in persons with epilepsy. Epilepsia 27(3):248–254. https://doi.org/10.1111/j.1528-1157.1986.tb03536.x
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature;Medicina;2023-07-28
2. Cenobamate in Generalized Epilepsy and Combined Generalized and Focal Epilepsy;Neurology Clinical Practice;2023-04
3. Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain;Expert Review of Pharmacoeconomics & Outcomes Research;2022-08-03
4. Epilepsie im Alter;DMW - Deutsche Medizinische Wochenschrift;2022-05-30
5. The efficacy of lamotrigine after failure of the first administration of valproate in treating epilepsy: a systematic review and meta-analysis;Annals of Palliative Medicine;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3